BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24235108)

  • 1. Adverse drug effect detection.
    Lian Duan L; Khoshneshin M; Street WN; Liu M
    IEEE J Biomed Health Inform; 2013 Mar; 17(2):305-11. PubMed ID: 24235108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Space complexity of estimation of distribution algorithms.
    Gao Y; Culberson J
    Evol Comput; 2005; 13(1):125-43. PubMed ID: 15901429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid Assessment of Adverse Drug Reactions by Statistical Solution of Gene Association Network.
    Xiang YP; Liu K; Cheng XY; Cheng C; Gong F; Pan JB; Ji ZL
    IEEE/ACM Trans Comput Biol Bioinform; 2015; 12(4):844-50. PubMed ID: 26357325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of distribution algorithms with Kikuchi approximations.
    Santana R
    Evol Comput; 2005; 13(1):67-97. PubMed ID: 15901427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Globally multimodal problem optimization via an estimation of distribution algorithm based on unsupervised learning of Bayesian networks.
    Peña JM; Lozano JA; Larrañaga P
    Evol Comput; 2005; 13(1):43-66. PubMed ID: 15901426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive modeling of structured electronic health records for adverse drug event detection.
    Zhao J; Henriksson A; Asker L; Boström H
    BMC Med Inform Decis Mak; 2015; 15 Suppl 4(Suppl 4):S1. PubMed ID: 26606038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP).
    Hauben M; Aronson JK; Ferner RE
    Drug Saf; 2016 May; 39(5):421-32. PubMed ID: 26879560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weighted lasso in graphical Gaussian modeling for large gene network estimation based on microarray data.
    Shimamura T; Imoto S; Yamaguchi R; Miyano S
    Genome Inform; 2007; 19():142-53. PubMed ID: 18546512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of reporting bias in the analysis of spontaneous reporting data.
    Ghosh P; Dewanji A
    Pharm Stat; 2015; 14(1):20-5. PubMed ID: 25376637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new dataset evaluation method based on category overlap.
    Oh S
    Comput Biol Med; 2011 Feb; 41(2):115-22. PubMed ID: 21216397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of statistical methods for safety signal detection: a simulation study.
    Chen M; Zhu L; Chiruvolu P; Jiang Q
    Pharm Stat; 2015; 14(1):11-9. PubMed ID: 25329607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of censoring on learning Bayesian networks in survival modelling.
    Stajduhar I; Dalbelo-Basić B; Bogunović N
    Artif Intell Med; 2009 Nov; 47(3):199-217. PubMed ID: 19833488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bayesian recurrent neural network for unsupervised pattern recognition in large incomplete data sets.
    Orre R; Bate A; Norén GN; Swahn E; Arnborg S; Edwards IR
    Int J Neural Syst; 2005 Jun; 15(3):207-22. PubMed ID: 16013091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting motor vehicle collisions using Bayesian neural network models: an empirical analysis.
    Xie Y; Lord D; Zhang Y
    Accid Anal Prev; 2007 Sep; 39(5):922-33. PubMed ID: 17306751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expectation propagation with factorizing distributions: a Gaussian approximation and performance results for simple models.
    Ribeiro F; Opper M
    Neural Comput; 2011 Apr; 23(4):1047-69. PubMed ID: 21222527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian approach for clinical trial safety data using an Ising prior.
    McEvoy BW; Nandy RR; Tiwari RC
    Biometrics; 2013 Sep; 69(3):661-72. PubMed ID: 23845253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian pharmacovigilance signal detection methods revisited in a multiple comparison setting.
    Ahmed I; Haramburu F; Fourrier-Réglat A; Thiessard F; Kreft-Jais C; Miremont-Salamé G; Bégaud B; Tubert-Bitter P
    Stat Med; 2009 Jun; 28(13):1774-92. PubMed ID: 19360795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance.
    Xu Y; Zhou X; Suehs BT; Hartzema AG; Kahn MG; Moride Y; Sauer BC; Liu Q; Moll K; Pasquale MK; Nair VP; Bate A
    Drug Saf; 2015 Aug; 38(8):749-65. PubMed ID: 26055920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linkage problem, distribution estimation, and Bayesian networks.
    Pelikan M; Goldberg DE; Cantú-Paz E
    Evol Comput; 2000; 8(3):311-40. PubMed ID: 11001554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are all quantitative postmarketing signal detection methods equal? Performance characteristics of logistic regression and Multi-item Gamma Poisson Shrinker.
    Berlin C; Blanch C; Lewis DJ; Maladorno DD; Michel C; Petrin M; Sarp S; Close P
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):622-30. PubMed ID: 21994119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.